Dual-targeting cyclic peptides of receptor-binding domain (RBD) and main protease (Mpro) as potential drug leads for the treatment of SARS-CoV-2 infection

The receptor-binding domain (RBD) and the main protease (Mpro) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) play a crucial role in the entry and replication of viral particles, and co-targeting both of them could be an attractive approach for the treatment of SARS-CoV-2 infection...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zhen, Zou, Yunting, Gao, Xi, Niu, Miao-Miao, Li, Jindong, Xue, Lu, Jiang, Su
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627161/
https://www.ncbi.nlm.nih.gov/pubmed/36339564
http://dx.doi.org/10.3389/fphar.2022.1041331

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9627161/
https://www.ncbi.nlm.nih.gov/pubmed/36339564
http://dx.doi.org/10.3389/fphar.2022.1041331

Ejemplares similares